These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 10830085)

  • 1. [Cardiac insufficiency: prevention of ventricular arrhythmias].
    Mabo P; Leclercq C; Pavin D
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():23-8. PubMed ID: 10830085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of arrhythmias in patients with heart failure].
    Le Heuzey JY; Copie X; Piot O; Lavergne T; Henry P; Guize L
    Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1371-6. PubMed ID: 9864606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arrhythmia risk stratification based on etiological and anatomo-structural factors].
    Disertori M; Dallafior D; Marini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1265-9. PubMed ID: 11838346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-arrhythmic therapy and cardiac failure].
    Cosnay P; Babuty D; Charniot JC; Fauchier L; Fauchier JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88 Spec No 5():35-41. PubMed ID: 8729298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arrhythmia risk stratification in patients with heart failure. Foreword].
    Opasich C; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
    Ansalone G; Ricci R; Cacciatore G; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk stratification and prevention of sudden death in patients with heart failure].
    Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A
    Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    Das MK; Zipes DP
    J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of ventricular arrhythmia in chronic congestive heart failure].
    Pulignano G; Giovannini M; Del Sindaco D; Fera MS; Mazza A; Minardi G; Giovannini E
    Clin Ter; 1998; 149(4):297-305. PubMed ID: 9866892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variables of arrhythmia risk in relation to pacemaker and implantable defibrillator].
    Solano A; Oddone D; Croci F; Donateo P; Puggioni E; Brignole M
    Ital Heart J Suppl; 2001 Dec; 2(12):1303-7. PubMed ID: 11838352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of cardiac insufficiency: does treatment depend on whether its cause is ischemic or idiopathic?].
    Galinier M; Bounhoure JP
    Arch Mal Coeur Vaiss; 1999 Jun; 92(6):727-32. PubMed ID: 10410811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arrhythmia risk stratification in patients with heart failure: prognostic evaluation of arrhythmia risk].
    Lombardi F
    Ital Heart J Suppl; 2001 Dec; 2(12):1284-90. PubMed ID: 11838349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and prevention of sudden cardiac death--what have we learnt from randomised clinical trials?
    Kam RM; Teo WS; Koh TH; Lim YL
    Singapore Med J; 1999 Nov; 40(11):707-10. PubMed ID: 10709412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with the implantable cardioverter defibrillator (ICD)].
    Jordaens LJ
    Verh K Acad Geneeskd Belg; 1997; 59(2):107-33. PubMed ID: 9210850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiarrhythmic agents in the prevention of sudden cardiac death].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.